Buchumschlag

Qualitative Experiences and Depression/Anxiety Scores in Parents of Children With Cystic Fibrosis Transmembrane Conductance Regulator Related Metabolic Syndrome

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Lynne Carty, Rebecca Dobra, Jackie Francis, Michele Puckey, Andy Bush, Jane C. Davies
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Pediatric Pulmonology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Systematic Review of Nasal Endoscopy Scores in Cystic Fibrosis Patients Treated With Cystic Fibrosis Transmembrane Conductance Regulator Modulators
von: Rebecca Gallardo, et al.
Veröffentlicht: (2026)

Objectively Monitored Sleep in School‐Age Children With Cystic Fibrosis and Their Parents
von: Andrea L. Fidler, et al.
Veröffentlicht: (2025)

Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk
von: Tyler Shugg, et al.
Veröffentlicht: (2025)

Increasing Cystic Fibrosis Knowledge of Parents of Children Diagnosed With the Newborn Screening Program
von: Mine Yüksel Kalyoncu, et al.
Veröffentlicht: (2025)

Interrater Reliability of a Modified Bronchoscopy Scoring Tool in Children With Cystic Fibrosis
von: Alexandra Bosetti, et al.
Veröffentlicht: (2025)

The Dutch Gastrointestinal Symptom Tracker for People With Cystic Fibrosis: Associations With Anxiety, Depression, and Health‐Related Quality of Life
von: Marieke Verkleij, et al.
Veröffentlicht: (2025)

Anxiety in the Pediatric Cystic Fibrosis Population: Evaluation of a Younger Cohort
von: Jemilla Strode Smith, et al.
Veröffentlicht: (2025)

Impact of Number of Pharmacies on Dornase Alfa Medication Possession Ratio in Children With Cystic Fibrosis
von: Rebecca S. Pettit, et al.
Veröffentlicht: (2025)

“No Words for Feelings”: Alexithymia in Children With Cystic Fibrosis and Their Caregivers
von: Tuğba Şişmanlar Eyüboğlu, et al.
Veröffentlicht: (2026)

Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid
von: Laurie P. Murray, et al.
Veröffentlicht: (2025)

Tobramycin Pharmacokinetics in Pediatric People With Cystic Fibrosis on Maintenance Azithromycin
von: Chelsea Flora, et al.
Veröffentlicht: (2026)

Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series
von: Charissa W. Kam, et al.
Veröffentlicht: (2024)

The Frequency and Potential Implications of HFE Genetic Variants in Children With Cystic Fibrosis
von: Leslie Huang, et al.
Veröffentlicht: (2025)

Impact of Elexacaftor‐Tezacaftor‐Ivacaftor on Quality of Life in Children With Cystic Fibrosis
von: Sara Kümmerli, et al.
Veröffentlicht: (2026)

Elexacaftor/Tezacaftor/Ivacaftor Treatment Accessibility and Mental Health: Reducing Anxiety in People With Cystic Fibrosis
von: Burcu Uzunoglu, et al.
Veröffentlicht: (2025)

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fecal Elastase‐1 in Children With Cystic Fibrosis
von: Senthilkumar Sankararaman, et al.
Veröffentlicht: (2025)

Domain‐Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis
von: Jeremy P. Tervo, et al.
Veröffentlicht: (2025)

Risk Factors and Outcomes of Pulmonary Exacerbations in Infants and Young Children With Cystic Fibrosis
von: Aoife Corcoran, et al.
Veröffentlicht: (2025)

Effects of Elexacaftor‐Tezacaftor‐Ivacaftor on Nasal and Sinus Symptoms in Children With Cystic Fibrosis
von: Guillaume Petit, et al.
Veröffentlicht: (2025)

Infant Lung Function in Cystic Fibrosis: A Real‐World Study
von: Michele Arigliani, et al.
Veröffentlicht: (2025)

Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life
von: Elizabeth Clarke, et al.
Veröffentlicht: (2024)

Facilitators and Barriers to Increasing Equity in Cystic Fibrosis Newborn Screening Algorithms
von: Kellyn Madden, et al.
Veröffentlicht: (2024)

The Impact of Cystic Fibrosis‐Related Diabetes on Barriers to Self‐Management
von: Rebecca J. Vitale, et al.
Veröffentlicht: (2026)

Pathophysiology of Cystic Fibrosis Liver Disease
von: Vania L. Kasper, et al.
Veröffentlicht: (2024)

Roadmap to Global Cystic Fibrosis Care
von: Samya Z. Nasr, et al.
Veröffentlicht: (2025)

Cystic Fibrosis Year in Review 2024
von: Adrienne P. Savant
Veröffentlicht: (2025)

Home Cough Monitoring Reveals Higher Nighttime Cough Burden in Children With Cystic Fibrosis Compared With Healthy Children
von: Lilah D. Melzer, et al.
Veröffentlicht: (2025)

Real World Adverse Effects of Elexacaftor/Tezacaftor/Ivacaftor in People With Cystic Fibrosis Ages 6–11 Years
von: Rebecca S. Pettit, et al.
Veröffentlicht: (2025)

Development of a Simplified Arabic Questionnaire of Health‐Related Quality of Life for Children With Cystic Fibrosis
von: Heba A. Ali, et al.
Veröffentlicht: (2025)

Microbiological Profile of Airway in Indian Children With Cystic Fibrosis: A Multicenter Prospective Cohort Study
von: Prawin Kumar, et al.
Veröffentlicht: (2025)

Impact of Home Collection and Shipping of Respiratory Specimens on Bacterial Pathogen Detection in Children With Cystic Fibrosis
von: Jordana E. Hoppe, et al.
Veröffentlicht: (2025)

Expanding Cystic Fibrosis Registries to the Rest of the World
von: Lutz Naehrlich
Veröffentlicht: (2026)

Predictors of Selective Serotonin Reuptake Inhibitor Treatment Failure in Persons With Cystic Fibrosis
von: Rebecca S. Pettit, et al.
Veröffentlicht: (2024)

Commentary on “Impact of Home Collection and Shipping of Respiratory Specimens on Bacterial Pathogen Detection in Children With Cystic Fibrosis”
von: Ahmet Kağan Özkaya, et al.
Veröffentlicht: (2025)

Real‐World Impact of Elexacaftor/Tezacaftor/Ivacaftor in Israeli Children Aged 2–6 With Cystic Fibrosis
von: Adi Dagan, et al.
Veröffentlicht: (2026)

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
von: Cindy L. Williams, et al.
Veröffentlicht: (2025)

Exploring Exercise as Airway Clearance in Cystic Fibrosis: A Qualitative Study From the ExACT‐CF Feasibility Trial
von: Emily Taylor, et al.
Veröffentlicht: (2026)

Disparities in Access to Cystic Fibrosis Therapy Across Countries
von: Bulent Karadag
Veröffentlicht: (2026)

Effect of Camel Milk on the Spirometry Parameters of Children With Cystic Fibrosis: The First Double Blind Randomized Clinical Trial
von: Seyed Javad Sayedi, et al.
Veröffentlicht: (2025)

Early Diagnosis of Non‐Cystic Fibrosis Bronchiectasis in Childhood: Shedding Light on Barriers and Opportunities
von: Michele Ghezzi, et al.
Veröffentlicht: (2025)